Cargando…
Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study
PURPOSE: The objective of this study was to develop and validate a questionnaire, through a Delphi consensus, to be used by allergists in their routine clinical practice to assess the preferences of patients starting allergen immunotherapy (AIT) treatment using an objective approach. PATIENTS AND ME...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378527/ https://www.ncbi.nlm.nih.gov/pubmed/37520065 http://dx.doi.org/10.2147/PPA.S409466 |
_version_ | 1785079789160235008 |
---|---|
author | Antón, Mónica Cabañes, Nieves Fernández-Meléndez, Salvador Fernández-Nieto, Mar Jiménez-Ferrera, Gloria Letrán, Antonio Méndez-Brea, Paula Montoro, Javier Moreno, Francisco Mur-Gimeno, Pilar Rodríguez-Vázquez, Virginia Rosado, Ana Sánchez-Guerrero, Inmaculada Vega-Chicote, Jose Mª Vidal, Carmen |
author_facet | Antón, Mónica Cabañes, Nieves Fernández-Meléndez, Salvador Fernández-Nieto, Mar Jiménez-Ferrera, Gloria Letrán, Antonio Méndez-Brea, Paula Montoro, Javier Moreno, Francisco Mur-Gimeno, Pilar Rodríguez-Vázquez, Virginia Rosado, Ana Sánchez-Guerrero, Inmaculada Vega-Chicote, Jose Mª Vidal, Carmen |
author_sort | Antón, Mónica |
collection | PubMed |
description | PURPOSE: The objective of this study was to develop and validate a questionnaire, through a Delphi consensus, to be used by allergists in their routine clinical practice to assess the preferences of patients starting allergen immunotherapy (AIT) treatment using an objective approach. PATIENTS AND METHODS: A Delphi consensus-driven process was used. The scientific committee, composed of 15 allergists, led the study and participated in the preparation of the questionnaire. Two-hundred panelists from different Spanish regions were invited to complete a 16-item questionnaire on a nine-point Likert scale covering six topic blocks. Consensus was achieved if ≥66.6% of panelists reached agreement or disagreement. RESULTS: Of the 200 experts invited to participate in the Delphi process, a total of 195 (97.5%) answered the questionnaire. The panel experts reached a consensus on “agreement” on a total of 12 of the 16 (75.0%) items, covering a total of six categories: (a) patient knowledge (2 questions), (b) barriers to patient adherence (3 questions), (c) patient behavior (4 questions), (d) future actions (3 questions), (e) treatment costs (2 questions), and (f) final patient preferences (2 questions). CONCLUSION: This Delphi consensus study validated a set of twelve recommended questions for patients objectively assessing their preferences and suitability for the most common AIT options available. The questionnaire intends to assist allergists in making an objective, unconditioned decision regarding the best AIT option for each patient, after informing them about the different routes. |
format | Online Article Text |
id | pubmed-10378527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-103785272023-07-29 Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study Antón, Mónica Cabañes, Nieves Fernández-Meléndez, Salvador Fernández-Nieto, Mar Jiménez-Ferrera, Gloria Letrán, Antonio Méndez-Brea, Paula Montoro, Javier Moreno, Francisco Mur-Gimeno, Pilar Rodríguez-Vázquez, Virginia Rosado, Ana Sánchez-Guerrero, Inmaculada Vega-Chicote, Jose Mª Vidal, Carmen Patient Prefer Adherence Original Research PURPOSE: The objective of this study was to develop and validate a questionnaire, through a Delphi consensus, to be used by allergists in their routine clinical practice to assess the preferences of patients starting allergen immunotherapy (AIT) treatment using an objective approach. PATIENTS AND METHODS: A Delphi consensus-driven process was used. The scientific committee, composed of 15 allergists, led the study and participated in the preparation of the questionnaire. Two-hundred panelists from different Spanish regions were invited to complete a 16-item questionnaire on a nine-point Likert scale covering six topic blocks. Consensus was achieved if ≥66.6% of panelists reached agreement or disagreement. RESULTS: Of the 200 experts invited to participate in the Delphi process, a total of 195 (97.5%) answered the questionnaire. The panel experts reached a consensus on “agreement” on a total of 12 of the 16 (75.0%) items, covering a total of six categories: (a) patient knowledge (2 questions), (b) barriers to patient adherence (3 questions), (c) patient behavior (4 questions), (d) future actions (3 questions), (e) treatment costs (2 questions), and (f) final patient preferences (2 questions). CONCLUSION: This Delphi consensus study validated a set of twelve recommended questions for patients objectively assessing their preferences and suitability for the most common AIT options available. The questionnaire intends to assist allergists in making an objective, unconditioned decision regarding the best AIT option for each patient, after informing them about the different routes. Dove 2023-07-24 /pmc/articles/PMC10378527/ /pubmed/37520065 http://dx.doi.org/10.2147/PPA.S409466 Text en © 2023 Antón et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Antón, Mónica Cabañes, Nieves Fernández-Meléndez, Salvador Fernández-Nieto, Mar Jiménez-Ferrera, Gloria Letrán, Antonio Méndez-Brea, Paula Montoro, Javier Moreno, Francisco Mur-Gimeno, Pilar Rodríguez-Vázquez, Virginia Rosado, Ana Sánchez-Guerrero, Inmaculada Vega-Chicote, Jose Mª Vidal, Carmen Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study |
title | Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study |
title_full | Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study |
title_fullStr | Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study |
title_full_unstemmed | Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study |
title_short | Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study |
title_sort | shared decision-making in allergen immunotherapy (ait) options using a questionnaire for respiratory allergic patients: a delphi consensus study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378527/ https://www.ncbi.nlm.nih.gov/pubmed/37520065 http://dx.doi.org/10.2147/PPA.S409466 |
work_keys_str_mv | AT antonmonica shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT cabanesnieves shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT fernandezmelendezsalvador shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT fernandeznietomar shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT jimenezferreragloria shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT letranantonio shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT mendezbreapaula shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT montorojavier shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT morenofrancisco shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT murgimenopilar shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT rodriguezvazquezvirginia shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT rosadoana shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT sanchezguerreroinmaculada shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT vegachicotejosema shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy AT vidalcarmen shareddecisionmakinginallergenimmunotherapyaitoptionsusingaquestionnaireforrespiratoryallergicpatientsadelphiconsensusstudy |